Language Select
Varian Logo

Press Releases

December 06, 2018
At a ribbon-cutting ceremony today in Atlanta, Georgia, the Varian-equipped Emory Proton Therapy Center officially opened. This five-treatment room facility features the Varian ProBeam® proton... Read more
December 03, 2018
Varian (NYSE: VAR) today announced that its Board of Directors has scheduled the 2019 Annual Meeting of Stockholders for February 14, 2019 with a record date of December 17, 2018. The meeting will... Read more
November 30, 2018
HollandPTC in Delft, Netherlands, opened today equipped with the ProBeam® proton therapy system from Varian (NYSE: VAR). The center, which recently treated its first patient, features two... Read more
November 28, 2018
Continuing to expand access to cancer care globally, Varian (NYSE: VAR) announced it was selected by Medical Specialist Holdings (MSH) to equip seven of its centers in South Africa with Varian... Read more
November 28, 2018
Varian (NYSE: VAR) today announced its Halcyon™ system has been approved by the China National Medical Product Administration (NMPA), which allows the company to market this new cancer treatment... Read more
November 20, 2018
Varian (NYSE: VAR) today announced that Anat Ashkenazi, senior vice president, controller and chief financial officer (CFO) at Lilly Research Labs, has been appointed to the Varian Board of... Read more
November 19, 2018
Varian (NYSE: VAR) today announced that Gary Bischoping, chief financial officer, will present at the Citi Global Healthcare Conference in New York City, scheduled for 11:00 a.m. Eastern Time on... Read more
November 14, 2018
Varian (NYSE: VAR) today announced the publication of its annual Sustainability Report, detailing the company's initiatives and achievements in extending access to cancer care, protecting... Read more
November 05, 2018
On October 19th, 2018, IDC, the world's leading digital research firm, announced Beijing Cancer Hospital won a "2018 IDC China Digital Transformation Annual Award" in the category of Operating... Read more
October 23, 2018
Varian (NYSE: VAR) and GenesisCare, a leading provider of cancer care treatment, today announced the signing of a memorandum of understanding (MoU) to form a strategic partnership for cancer care... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com